TY  - GEN
AU  - Magro, Margarita
AU  - Mas-Lloret, Vicente
AU  - Chappell, Keith
AU  - Vazquez-Alcaraz, Monica
AU  - Cano, Olga
AU  - Luque, Daniel
AU  - Terrón-Orellana, Maria Carmen
AU  - Melero, Jose Antonio
AU  - Palomo-Sanz, Concepcion
PY  - 2012
DO  - 10.1073/pnas.1115941109
UR  - http://hdl.handle.net/20.500.12105/17487
AB  - Human respiratory syncytial virus (hRSV) is the most important viral agent of pediatric respiratory infections worldwide. The only specific treatment available today is a humanized monoclonal antibody (Palivizumab) directed against the F glycoprotein,...
LA  - eng
PB  - National Academy of Sciences
KW  - Amino Acid Sequence
KW  - Animals
KW  - Antibodies, Neutralizing
KW  - Antibodies, Viral
KW  - Humans
KW  - Immunization
KW  - Molecular Sequence Data
KW  - Protein Stability
KW  - Rabbits
KW  - Recombinant Proteins
KW  - Respiratory Syncytial Virus Infections
KW  - Respiratory Syncytial Virus, Human
KW  - Vaccinia virus
KW  - Viral Fusion Proteins
TI  - Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
TY  - research article
ER  -